Riskpilot← Back to searchSign inGet full accessFerrosan Medical Devices Group A/S
A/SActiveCVR 43531093Sydmarken 5Business and other management consultancy activities · NACE 7020Est. 20223 employees
Revenue 2024
DKK 996,7M
+12% vs 2023
EBITDA margin
31.6%
+48% vs 2023
Equity ratio
50.3%
Financial strength
Net profit 2024
DKK 95,3M
+299% vs 2023
| Revenue | DKK 996,7M | +12% |
| EBITDA | DKK 315M | +48% |
| Net profit | DKK 95,3M | +299% |
| Total assets | DKK 5,8B | +3% |
| Equity | DKK 2,9B | +3% |
| Employees | 3 | — |
Legal name
Ferrosan Medical Devices Group A/S
CVR number
43531093
Legal form
Aktieselskab
NACE code
7020 · Business and other management consultancy activities
Founded
22. september 2022
Share capital
DKK 400.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse, eller af to bestyrelsesmedlemmer i forening eller af en direktør i forening med bestyrelsens formand
Company purpose
Selskabets formål er (i) at udøve management services, (ii) at ansætte medarbejdere, (iii) at investere i og besidde aktier og finansielle instrumenter samt (iv) at drive anden virksomhed, der efter direktionens skøn er direkte eller indirekte forbundet hermed.
Address
Sydmarken 5
Phone
+4570252860
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | -47.649 | 893.367 | 996.720 |
| Staff expenses | -137 | -214.949 | -236.994 |
| EBITDA | -47.786 | 212.579 | 315.013 |
| Depreciation & amort. | -0 | -23.292 | -24.458 |
| EBIT | -47.786 | 189.287 | 290.555 |
| Net financials | -1.941 | -132.781 | -133.669 |
| Profit before tax | -49.727 | 56.506 | 156.886 |
| Tax | -426 | 32.643 | 61.602 |
| Net profit | -49.301 | 23.863 | 95.284 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 4.689.078 | 5.642.539 | 5.832.681 |
| Equity | 2.835.619 | 2.837.941 | 2.932.040 |
| Long-term debt | 1.821.141 | 2.477.414 | 2.467.599 |
| Short-term debt | 32.318 | 327.184 | 433.042 |
| Total debt | 1.853.459 | 2.804.598 | 2.900.641 |
EBITDA margin
31.6%
This company
15.8%
Market median
+100% vs market
20222024
Equity ratio
50.3%
This company
38.2%
Market median
+32% vs market
20222024
Return on equity
3.2%
This company
18.4%
Market median
-83% vs market
20222024
Net profit margin
9.6%
This company
8.1%
Market median
+19% vs market
20222024
Asset turnover
0.17×
This company
1.12×
Market median
-85% vs market
20222024
Debt / equity
0.99×
This company
0.62×
Market median
+60% vs market
20222024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-09-22 – 2022-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HH Management | Management | 2023 | — | — |
AB Management | Management | 2022 | — | — |
RH Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Ferrosan Medical Devices MidCo ApS | Company | 100.0% | 100.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
LUNDBECKFOND INVEST A/SFerrosan Medical Devices HoldCo ApSFerrosan Medical Devices MidCo ApS
Ferrosan Medical Devices Group A/S (this company)Board members of Ferrosan Medical Devices Group A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Henrik Pauk Pedersen | Management | 0 companies |
| Anja Bach Eriksson | Management | 0 companies |
| Rasmus Hother le Fevre | Chief Executive Officer | 0 companies |
| Peter Henrik Kürstein-Jensen | Chairman | 0 companies |
| Mia Bielecki | Board of Directors | 0 companies |
| Staffan Percy Ternström | Board of Directors | 0 companies |
| Kim Gulstad | Deputy Chairman | 0 companies |
| Allan Bjørn Rasmussen | Board of Directors | 0 companies |
| Anders Christian Schelde | Board of Directors | 0 companies |
| Arne Due-Hansen | Board of Directors | 0 companies |